A Novel Promoter CpG-Based Signature for Long-Term Survival Prediction of Breast Cancer Patients

DNA methylation has been reported as one of the most critical epigenetic aberrations during the tumorigenesis and development of breast cancer (BC). This study explored a novel promoter CpG-based signature for long-term survival prediction of BC patients. We used The Cancer Genome Atlas (TCGA) data...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yang, Mao, Xiaoyun, Qiao, Zhen, Chen, Bo, Jin, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606941/
https://www.ncbi.nlm.nih.gov/pubmed/33194705
http://dx.doi.org/10.3389/fonc.2020.579692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606941/
https://www.ncbi.nlm.nih.gov/pubmed/33194705
http://dx.doi.org/10.3389/fonc.2020.579692

Ejemplares similares